318 related articles for article (PubMed ID: 28974890)
1. Dihydromyricetin-mediated inhibition of the Notch1 pathway induces apoptosis in QGY7701 and HepG2 hepatoma cells.
Lu CJ; He YF; Yuan WZ; Xiang LJ; Zhang J; Liang YR; Duan J; He YH; Li MY
World J Gastroenterol; 2017 Sep; 23(34):6242-6251. PubMed ID: 28974890
[TBL] [Abstract][Full Text] [Related]
2. Dihydromyricetin reduced Bcl-2 expression via p53 in human hepatoma HepG2 cells.
Wu S; Liu B; Zhang Q; Liu J; Zhou W; Wang C; Li M; Bao S; Zhu R
PLoS One; 2013; 8(11):e76886. PubMed ID: 24223706
[TBL] [Abstract][Full Text] [Related]
3. Notch1 downregulation combined with interleukin-24 inhibits invasion and migration of hepatocellular carcinoma cells.
Han B; Liu SH; Guo WD; Zhang B; Wang JP; Cao YK; Liu J
World J Gastroenterol; 2015 Sep; 21(33):9727-35. PubMed ID: 26361419
[TBL] [Abstract][Full Text] [Related]
4. Dihydromyricetin inhibits migration and invasion of hepatoma cells through regulation of MMP-9 expression.
Zhang QY; Li R; Zeng GF; Liu B; Liu J; Shu Y; Liu ZK; Qiu ZD; Wang DJ; Miao HL; Li MY; Zhu RZ
World J Gastroenterol; 2014 Aug; 20(29):10082-93. PubMed ID: 25110435
[TBL] [Abstract][Full Text] [Related]
5. Dihydromyricetin induces mouse hepatoma Hepal-6 cell apoptosis via the transforming growth factor-β pathway.
Liu B; Zhou W; Chen X; Xu F; Chen Y; Liu J; Zhang Q; Bao S; Chen N; Li M; Zhu R
Mol Med Rep; 2015 Mar; 11(3):1609-14. PubMed ID: 25376731
[TBL] [Abstract][Full Text] [Related]
6. Guggulsterone induces apoptosis of human hepatocellular carcinoma cells through intrinsic mitochondrial pathway.
Shi JJ; Jia XL; Li M; Yang N; Li YP; Zhang X; Gao N; Dang SS
World J Gastroenterol; 2015 Dec; 21(47):13277-87. PubMed ID: 26715810
[TBL] [Abstract][Full Text] [Related]
7. Dihydromyricetin induces mitochondria-mediated apoptosis in HepG2 cells through down-regulation of the Akt/Bad pathway.
Zhang Z; Zhang H; Chen S; Xu Y; Yao A; Liao Q; Han L; Zou Z; Zhang X
Nutr Res; 2017 Feb; 38():27-33. PubMed ID: 28381351
[TBL] [Abstract][Full Text] [Related]
8. TQ inhibits hepatocellular carcinoma growth in vitro and in vivo via repression of Notch signaling.
Ke X; Zhao Y; Lu X; Wang Z; Liu Y; Ren M; Lu G; Zhang D; Sun Z; Xu Z; Song JH; Cheng Y; Meltzer SJ; He S
Oncotarget; 2015 Oct; 6(32):32610-21. PubMed ID: 26416455
[TBL] [Abstract][Full Text] [Related]
9. Golgi reassembly and stacking protein 65 downregulation is required for the anti-cancer effect of dihydromyricetin on human ovarian cancer cells.
Wang F; Chen X; Yuan D; Yi Y; Luo Y
PLoS One; 2019; 14(11):e0225450. PubMed ID: 31770410
[TBL] [Abstract][Full Text] [Related]
10. Dihydromyricetin suppresses the proliferation of hepatocellular carcinoma cells by inducing G2/M arrest through the Chk1/Chk2/Cdc25C pathway.
Huang H; Hu M; Zhao R; Li P; Li M
Oncol Rep; 2013 Nov; 30(5):2467-75. PubMed ID: 24002546
[TBL] [Abstract][Full Text] [Related]
11. Dioscin suppresses hepatocellular carcinoma tumor growth by inducing apoptosis and regulation of TP53, BAX, BCL2 and cleaved CASP3.
Zhang G; Zeng X; Zhang R; Liu J; Zhang W; Zhao Y; Zhang X; Wu Z; Tan Y; Wu Y; Du B
Phytomedicine; 2016 Nov; 23(12):1329-1336. PubMed ID: 27765352
[TBL] [Abstract][Full Text] [Related]
12. Anticancer effects of dihydromyricetin on the proliferation, migration, apoptosis and in vivo tumorigenicity of human hepatocellular carcinoma Hep3B cells.
Jiang L; Ye WC; Li Z; Yang Y; Dai W; Li M
BMC Complement Med Ther; 2021 Jul; 21(1):194. PubMed ID: 34229692
[TBL] [Abstract][Full Text] [Related]
13. A novel all-trans retinoic acid derivative 4-amino‑2‑trifluoromethyl-phenyl retinate inhibits the proliferation of human hepatocellular carcinoma HepG2 cells by inducing G0/G1 cell cycle arrest and apoptosis via upregulation of p53 and ASPP1 and downregulation of iASPP.
Liu H; Chen F; Zhang L; Zhou Q; Gui S; Wang Y
Oncol Rep; 2016 Jul; 36(1):333-41. PubMed ID: 27177208
[TBL] [Abstract][Full Text] [Related]
14. Segetoside I, a plant-derived bisdesmosidic saponin, induces apoptosis in human hepatoma cells in vitro and inhibits tumor growth in vivo.
Firempong CK; Zhang HY; Wang Y; Chen J; Cao X; Deng W; Zhou J; Wang Q; Tong SS; Yu J; Xu X
Pharmacol Res; 2016 Aug; 110():101-110. PubMed ID: 27180010
[TBL] [Abstract][Full Text] [Related]
15. 1,25(OH)
Huang J; Yang G; Huang Y; Zhang S
Biochimie; 2018 Mar; 146():28-34. PubMed ID: 29158005
[TBL] [Abstract][Full Text] [Related]
16. A reduction in reactive oxygen species contributes to dihydromyricetin-induced apoptosis in human hepatocellular carcinoma cells.
Liu B; Tan X; Liang J; Wu S; Liu J; Zhang Q; Zhu R
Sci Rep; 2014 Nov; 4():7041. PubMed ID: 25391369
[TBL] [Abstract][Full Text] [Related]
17. Rhamnetin induces sensitization of hepatocellular carcinoma cells to a small molecular kinase inhibitor or chemotherapeutic agents.
Jia H; Yang Q; Wang T; Cao Y; Jiang QY; Ma HD; Sun HW; Hou MX; Yang YP; Feng F
Biochim Biophys Acta; 2016 Jul; 1860(7):1417-30. PubMed ID: 27091611
[TBL] [Abstract][Full Text] [Related]
18. Involvement of the prostaglandin E receptor EP2 in paeoniflorin-induced human hepatoma cell apoptosis.
Hu S; Sun W; Wei W; Wang D; Jin J; Wu J; Chen J; Wu H; Wang Q
Anticancer Drugs; 2013 Feb; 24(2):140-9. PubMed ID: 23069790
[TBL] [Abstract][Full Text] [Related]
19. Simvastatin induces growth inhibition and apoptosis in HepG2 and Huh7 hepatocellular carcinoma cells via upregulation of Notch1 expression.
Huang X; Ma J; Xu J; Su Q; Zhao J
Mol Med Rep; 2015 Mar; 11(3):2334-40. PubMed ID: 25412322
[TBL] [Abstract][Full Text] [Related]
20. Gambogenic acid induced mitochondrial-dependent apoptosis and referred to phospho-Erk1/2 and phospho-p38 MAPK in human hepatoma HepG2 cells.
Yan F; Wang M; Li J; Cheng H; Su J; Wang X; Wu H; Xia L; Li X; Chang HC; Li Q
Environ Toxicol Pharmacol; 2012 Mar; 33(2):181-90. PubMed ID: 22222560
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
